Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study

INTRODUCTION: Guselkumab previously showed greater improvements versus placebo in axial symptoms in patients with psoriatic arthritis (PsA) (assessed by Bath Ankylosing Spondylitis Disease Activity Index [BASDAI] and Ankylosing Spondylitis Disease Activity Score [ASDAS]), in post hoc analyses of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip J., Gladman, Dafna D., Poddubnyy, Denis, Chakravarty, Soumya D., Shawi, May, Kollmeier, Alexa P., Xu, Xie L., Xu, Stephen, Deodhar, Atul, Baraliakos, Xenofon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654317/
https://www.ncbi.nlm.nih.gov/pubmed/37819505
http://dx.doi.org/10.1007/s40744-023-00592-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654317/
https://www.ncbi.nlm.nih.gov/pubmed/37819505
http://dx.doi.org/10.1007/s40744-023-00592-8

Ejemplares similares